BUHLMANN Citations Archives - Page 7 of 14 - Buhlmann Diagnostics Corp

Category: BUHLMANN Citations

A number of the publications in the citation list describe applications that are outside of product claims thus they should be used for information only.

Analytical and Diagnostic Performance of Two Automated Fecal Calprotectin Immunoassays for Detection of Inflammatory Bowel Disease

BÜHLMANN fCAL® turbo: De Sloovere, M. et al. Analytical and diagnostic performance of two automated fecal calprotectin immunoassays for detection of inflammatory bowel disease, Clin Chem Lab Med. 2017 Aug 28;55(9):1435-1446. PMID: 28076305  DOI: 10.1515/cclm-2016-0796. Highlights from this Publication ““Bühlmann assays were superior with 100 % sensitivity…”.” Read Citation BÜHLMANN fCAL® turbo (K190784): FDA 510(k) cleared. For in vitro Diagnostic Use. Health
Continue Reading

Analytical Evaluation of a Fully Automated Immunoassay for Faecal Calprotectin in a Paediatric Setting

BÜHLMANN fCAL® turbo: Noebauer, B., Ramic, L. et al. Analytical evaluation of a fully automated immunoassay for faecal calprotectin in a paediatric setting.  Biochemia Medica, 2017;27(3):030710. DOI: 10.11613/BM.2017.030710 Highlights from this Publication “ ...With its fine performance characteristics, its strong correlation with the reference method ELISA and its convenient handling, it is a new analytical option for the rapid
Continue Reading

Diagnostics of anti-MAG antibody polyneuropathy

Anti-MAG Autoantibodies ELISA: Franciotta,D., Gastaldi, M., et al. Diagnostics of anti-MAG antibody polyneuropathy.  Neurological Sciences; (2017) 38(Suppl 2): 249. PMID: 29030772 DOI: 10.1007/s10072-017-3024-4 Highlights from this Publication “This document presents the guidelines for anti-myelin-associated glycoprotein (MAG) antibody testing that have been developed following a consensus process built on questionnaire-based surveys, internet contacts, and discussions at workshops of sponsoring Italian Association of
Continue Reading

Fecal Calprotectin: A Reliable Predictor of Mucosal Healing after Treatment for Active Ulcerative Colitis

BÜHLMANN fCAL® ELISA: Kristensen, V., A. Roseth, et al.  Fecal Calprotectin: A Reliable Predictor of Mucosal Healing after Treatment for Active Ulcerative Colitis.  Gastroenterology Research and Practice; Volume 2017 (2017), Article ID 2098293, 5 pages.  DOI: 10.1155/2017/2098293. Highlights from this Publication “Conclusions. Fecal calprotectin <250 μg/g after medical treatment for active ulcerative colitis is a reliable marker of endoscopic
Continue Reading

Do Not Forget About Pre-Analytics in Faecal Calprotectin Measurement!

BÜHLMANN fCAL® turbo and CALEX® Cap: Oyaert, M., Van den Bremt, S. et al. Do not forget about pre-analytics in faecal calprotectin measurement! Clinica Chimica Acta. 2017 Oct; 473:124-126. doi:10.1016/j.cca.2017.08.025. PMID: 28847684 . Highlights from this Publication This study found an optimal stability of fecal calprotectin when sampled with CALEX® extraction buffer and stored at 2-8 °C for 7 days. Furthermore, the
Continue Reading

Development of a Robust Automated 384-well Whole Blood Flow Cytometry Assay

Flow CAST®Kinase Inhibition Assay Citation: Wise S. et al. Development of a Robust Automated 384-well Whole Blood Flow Cytometry Assay. SLAS 2014. 3rd Annual Conference & Exhibition. January 18-22, 2014. San Diego, CA Highlights from this Poster "Monitoring basophil activation in whole blood via flow cytometry is an accurate method for measuring a pharmacodynamic response
Continue Reading

Data-Driven Programmatic Approach to Analysis of Basophil Activation Tests

Flow CAST® Assay: Sarita U. Patil et al. Data-Driven Programmatic Approach to Analysis of Basophil Activation Tests Cytometry B Clin Cytom. 2017 Jun 15. doi: 10.1002/cyto.b.21537. PMID: 28618453. Highlights from this Publication Peanut Flow CAST® assay has been the core standardize assay for the first evaluation of  on an automated analysis of Basophil activation test results. Flow CAST® results
Continue Reading

Diagnostic Accuracy of Fecal Calprotectin in Assessing the Severity of Inflammatory Bowel Disease: From Laboratory to Clinic

BÜHLMANN fCAL® ELISA: S. Moein, D. Quujeq et al. Diagnostic accuracy of fecal calprotectin in assessing the severity of inflammatory bowel disease: From laboratory to clinic. Caspian J Intern Med 2017; 8(3):178-182 DOI: 10.22088/cjim.8.3.178. Highlights from this Publication “ The current study also suggested 78.4 µg/g as the cut-off level for FC by 100% sensitivity and
Continue Reading

Turbidimetric Determination of Fecal Calprotectin Using Two Table Top Chemistry Analyzers: Mindray BS-200E and Cobas® c111

BÜHLMANN fCAL® turbo: Mandic-Havelka, A. Nilsen, T. et. al. Turbidimetric Determination of Fecal Calprotectin Using Two Table Top Chemistry Analyzers: Mindray BS-200E and Cobas® c111.  Clin Lab.  2017 May 1;63(5):907-913. doi: 10.7754/Clin.Lab.2016.161032.  PMID: 28627817 Highlights from this Publication “The assay was linear in the range between 20 and 1,900 µg/g with a limit of quantification around 20
Continue Reading

Agreement Between Home-based Measurement of Stool Calprotectin and ELISA Results for Monitoring Inflammatory Bowel Disease Activity

IBDoc® Citation: Heida A, Knol M, Kobold AM, Bootsman J, Dijkstra G, van Rheenen PF, Agreement Between Home-based Measurement of Stool Calprotectin and ELISA Results for Monitoring Inflammatory Bowel Disease Activity, Clinical Gastroenterology and Hepatology (2017) Jun 9. pii: S1542-3565(17)30712-7. DOI:10.1016/j.cgh.2017.06.007,  PMID:28606846. Highlights from this Publication “… we showed that the smartphone reader used by patients
Continue Reading